A multicenter, multinational analysis of mitomycin C in refractory metastatic colorectal cancer

This publication has 24 references indexed in Scilit:

• Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer
  Journal of Clinical Oncology, 2010
• Phase 1 clinical trials in 83 patients with pancreatic cancer
  Cancer, 2010
• Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
  New England Journal of Medicine, 2009
• Randomized, Controlled Trial of Irinotecan Plus Infusional, Bolus, or Oral Fluoropyrimidines in First-Line Treatment of Metastatic Colorectal Cancer: Results From the BICC-C Study
  Journal of Clinical Oncology, 2007
• Chemotherapy with Mitomycin C and Capecitabine in Patients with Advanced Colorectal Cancer Pretreated with Irinotecan and Oxaliplatin
  Tumori Journal, 2006
• Global Cancer Statistics, 2002
  CA: A Cancer Journal for Clinicians, 2005
• Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
  New England Journal of Medicine, 2004
• FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study
  Journal of Clinical Oncology, 2004
• Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer
  The Lancet, 1998
• A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer
  Annals of Oncology, 1997